Cardlytics Q2 revenue slightly misses estimates as billings fall
Cardlytics Q2 revenue slightly misses estimates as billings fall
Overview
Purchase intelligence platform's Q2 revenue fell 36% yr/yr, slightly missing analyst expectations
Adjusted EBITDA dropped to $1.7 mln from $3.0 mln a year earlier
Company expects Q3 revenue and billings to decline yr/yr
Outlook
Cardlytics sees Q3 2026 billings between $61.0 mln and $67.0 mln
Company expects Q3 2026 revenue of $34.0 mln to $39.0 mln
Cardlytics projects Q3 2026 adjusted EBITDA between $0 and $3.0 mln
Result Drivers
BILLINGS DECLINE - Billings fell 34% yr/yr to $65.5 mln, weighing on revenue
LOWER USER METRICS - Monthly qualified users fell 17% yr/yr and adjusted contribution per user declined to $0.11 from $0.14
MARGIN IMPROVEMENT - Co said margins improved every month during the quarter, per CEO Amit Gupta
Company press release: ID:nBw8ctMQxa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Slight Miss* | $36.88 mln | $37.003 mln (3 Analysts) |
Q2 Net Loss |
| $14.88 mln |
|
Q2 Billings |
| $65.47 mln |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy."
Wall Street's median 12-month price target for Cardlytics Inc is $10.00, about 148.8% above its August 4 closing price of $4.02
Reuters Recommended Reads
Aug 5 - Digital ad firm Taboola's Q2 revenue rises, but misses estimates
Aug 4 - Zeta Global beats Q2 revenue estimates on AI infrastructure demand; hikes forecast
Aug 3 - Ibotta Q2 revenue beats estimates on redemption growth
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Cardlytics
See all newsCardlytics Inc reports results for the quarter ended June 30 - Earnings Summary
Cardlytics Q2 revenue slightly misses estimates as billings fall
Cardlytics Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Cardlytics Appoints Chris Cheng As Chief Legal Officer